Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436666 (6-(3-(5-((4- (dimethylamino)-4-(3- hydroxyphenyl)p...) | PDB GoogleScholar | UniChem | Article US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436621 ((S)-2-methoxy-9- methyl-6-(2-methyl- 4-(3-(methyla...) | PDB GoogleScholar | UniChem | Article US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436625 ((S)-6-(2-fluoro-4-(3- (methylamino)-1- (thiophen-2...) | PDB GoogleScholar | UniChem | Article US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436666 (6-(3-(5-((4- (dimethylamino)-4-(3- hydroxyphenyl)p...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436318 (2-(ethylamino)-9- methyl-6-(3-(5-methyl- 1,3,4-oxa...) | PDB GoogleScholar | UniChem | Article US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436666 (6-(3-(5-((4- (dimethylamino)-4-(3- hydroxyphenyl)p...) | PDB GoogleScholar | UniChem | Article US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436574 ((S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436584 ((R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- (thiop...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436607 ((S)-8-(ethylamino)-1- methyl-4-(4-(3- (methylamino...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436609 ((S)-8-methoxy-1- methyl-4-(4-(3- (methylamino)-1- ...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436611 (2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1- (thi...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436626 ((S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- ...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436641 ((S)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436448 (2,9-dimethyl-6-(3-((3- (methylamino)-1- (thiophen-...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436454 (8-(dimethylamino)-1- methyl-4-(3-(3- (methylamino)...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436389 ((R)-9-methyl-6-(3-((3- (methylamino)-1- phenylprop...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436407 (6-(3-(4- ((benzylamino)methyl)- 1H-1,2,3-triazol-1...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436643 ((S)-2-(dimethylamino)- 9-methyl-6-(4-(3- (methylam...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436659 (9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436660 ((S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436480 (6-(3-(5- ((benzyl(methyl)amino) methyl)-1,3,4- oxa...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436486 (2-(ethylamino)-9- methyl-6-(3-(1- phenethylpiperid...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436495 (2-(ethylamino)-9- methyl-6-(3-(2- (methyl(phenethy...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436500 (2-(ethylamino)-6-(3-(2-(4- (3-hydroxyphenyl) piper...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436509 (6-(3-(4- (((cyclopropylmethyl) amino)methyl)-1H- 1...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436510 (2-(ethylamino)-6-(3-(4- ((ethylamino)methyl)- 1H-1...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436454 (8-(dimethylamino)-1- methyl-4-(3-(3- (methylamino)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436517 (6-(3-(4-((4- (dimethylamino)-4-(3- hydroxyphenyl)p...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436555 ((S)-8-methoxy-1- methyl-4-(3-(3- (methylamino)-1- ...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436481 (6-(3-(3- (benzyl(methyl)amino) propoxy)phenyl)-2- ...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436490 (2-(ethylamino)-9- methyl-6-(3-(2- (methyl(phenethy...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436490 (2-(ethylamino)-9- methyl-6-(3-(2- (methyl(phenethy...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436500 (2-(ethylamino)-6-(3-(2-(4- (3-hydroxyphenyl) piper...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436574 ((S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436584 ((R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- (thiop...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436513 (2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(pyridin...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436547 (1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436565 ((R)-9-methyl-2- (methyl(pyridin-2- ylmethyl)amino)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436605 (1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436606 ((S)-1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436584 ((R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- (thiop...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436588 ((S)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436599 ((S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- ...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436394 (6-(3-(3- (benzylamino)propoxy) phenyl)-2- (ethylam...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436603 ((S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436613 ((S)-1-ethyl-8- methoxy-4-(4-(3- (methylamino)-1- (...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436616 (2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1-(5- m...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436437 ((R)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamin...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103) (Homo sapiens (Human)) | BDBM436471 (6-(3-(4- (((cyclopropylmethyl) (methyl)amino)methy...) | PDB GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Monoamine transporter (Homo sapiens (Human)) | BDBM436643 ((S)-2-(dimethylamino)- 9-methyl-6-(4-(3- (methylam...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | UniChem | Article US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) Article DOI: null | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Displayed 1 to 50 (of 785 total ) | Next | Last >> |
